top of page
Under the leadership of Chief Executive Officer Thane Wettig, FibroGen’s executive team includes accomplished leaders with deep and broad experience. Supported by a staff of approximately 475 employees worldwide, we are focused on delivering first-in-class medicines for the treatment of unmet medical needs.
We are putting substantial expertise to work in
developing and commercializing novel therapeutics.
bottom of page